Skip to content

Clinical trials

Phase 3 Attention Deficit Disorder with Hyperactivity trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Attention Deficit Disorder with Hyperactivity Phase: Phase 3 Clear all

204 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20002
20011
20022
20036
200415
200515
200613
200711
200811
200910
20107
201112
20125
20135
20149
201511
20166
201712
20186
20199
20204
20211
20224
20234
20245
20253
20265

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed174
Terminated10
Recruiting9
Withdrawn5
Unknown status2
Not yet recruiting1
Suspended1
Enrolling by invitation1
Active, not recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Shire29
Eli Lilly and Company21
Supernus Pharmaceuticals, Inc.12
Otsuka Pharmaceutical Development & Commercialization, Inc.8
Rhodes Pharmaceuticals, L.P.7
Sumitomo Pharma America, Inc.7
Novartis5
Noven Therapeutics5
University of Cincinnati5
Alza Corporation, DE, USA4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Attention Deficit Disorder with Hyperactivity204
Spasm10
Oppositional Defiant Disorder7
Attention Deficit and Disruptive Behavior Disorders4
Anxiety Disorders3
Conduct Disorder3
Sleep Initiation and Maintenance Disorders3
Marijuana Abuse2
Mental Disorders2
Adjustment Disorders1

Trials

Showing 51 to 75 of 204. Each trial links to its page on Pharma Observatory.

104 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.